# OnCo record cdr-life (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cdr-life/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cdr-life" ;
  schema:name "CDR-Life"@en ;
  schema:description "CDR-Life develops T cell engagers, antibody-based medicines that bring the immune system's T cells into contact with cancer cells. Its cancer medicine CDR404 targets the MAGE-A4 protein and is in an early trial in solid tumours, now focusing on ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/cdr-life/>, <https://www.cdr-life.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.cdr-life.com/>, <https://clinicaltrials.gov/study/NCT06402201>, <https://www.cdr-life.com/wp-content/uploads/2025/10/pr-10-23-2025_CDR-Life-Presents-Early-Clinical-Data-Demonstrating-Pharmacodynamic-Activity-of-CDR404.pdf> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/mage-a4/> .